Phase II study evaluating the effect of concomitant ramucirumab (IMC-1121B; RAM) on the pharmacokinetics (PK) of paclitaxel (PTX) and the PK of RAM as monotherapy in patients (pts) with advanced malignant solid tumors.
Laura Quan Man Chow
Research Funding - ImClone Systems
David C. Smith
Research Funding - ImClone Systems
Antoinette R. Tan
Research Funding - ImClone Systems
Crystal Shereen Denlinger
Consultant or Advisory Role - Lilly
Research Funding - ImClone Systems
Ding Wang
Research Funding - ImClone Systems
Dale Randall Shepard
Research Funding - ImClone Systems
Archana Chaudhary
Employment or Leadership Position - Lilly
Stock Ownership - Lilly (B)
Yong Lin
Employment or Leadership Position - Lilly
Minori Koshiji
Employment or Leadership Position - Lilly
Stock Ownership - Lilly